BIOCRYST PHARMACEUTICALS INC — DEF 14A

BIOCRYST PHARMACEUTICALS INC of DURHAM, NC filed a DEF 14A with the SEC on 2023-04-27. Industry: Biological Products, (No Diagnostic Substances).

Filing

Documents (13)

SeqTypeDescription
1DEF 14ADEF 14A
2EX-101.SCHXBRL TAXONOMY EXTENSION SCHEMA
3EX-101.DEFXBRL TAXONOMY EXTENSION DEFINITION LINKBASE
4EX-101.LABXBRL TAXONOMY EXTENSION LABEL LINKBASE
5EX-101.PREXBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
6GRAPHIClogo_biocryst2a.jpg
7GRAPHICny20007126x1-pc_1.jpg
8GRAPHICny20007126x1-pc_2.jpg
9GRAPHICny20007126x1_barchart01.jpg
10GRAPHICny20007126x1_barchart02.jpg
11GRAPHICny20007126x1_barchart03.jpg
12GRAPHICny20007126x1_table01.jpg
15XMLEXTRACTED XBRL INSTANCE DOCUMENT

Filing timeline for this registrant (60)

Showing 12 of 60 filings.

FiledForm
2026-04-23DEF 14A
2026-04-23DEFA14A
2025-04-24DEF 14A
2025-04-24DEFA14A
2024-04-25DEF 14A
2024-04-25DEFA14A
2023-04-27DEFA14A
2023-04-27DEF 14A
2022-05-26DEFA14A
2022-04-25DEFA14A
2022-04-25DEF 14A
2021-04-13DEFA14A

More